Source: PharmiWeb

Relypsa: Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without F...

Read full article »
Relypsa's Competitors | Relypsa's News | Relypsa's Financials
Stay up-to-date with the latest news on Relypsa
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Patrick Treanor's photo - President of Relypsa

President

Patrick Treanor

CEO Approval Rating

77/100

Read more
Stay up-to-date with the latest news on Relypsa